Triple Antibiotic Ophthalmic Drops, Solution 0.025-1.75-10000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Triple Antibiotic: Ophthalmic drops, solution (0.025-1.75-10000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Neo/Poly B/Gram Ophth Soln
Drug Image file default-drug-image.png
Neo/Poly B/Gram Ophth Soln

What is this Medicine?

Gramicidin; Neomycin; Polymyxin B (gram i SYE din; nee oh MYE sin; pol i MIX in B) is an antibiotic. It is used in the eye to treat certain types of infections.

CVS Pharmacy Patient Statistics for Triple Antibiotic: Ophthalmic drops, solution(0.025-1.75-10000U)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Neomycin Sulfate/Polymyxin B Sulfate/Gramicidin Ophthalmic Solution

NDC: 005744009
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Keratoconjunctivitis, Keratitis, Blepharitis, Blepharoconjunctivitis, Ophthalmic Infection, Bacterial Conjunctivitis

Storage Information
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Neomycin Sulfate/Polymyxin B Sulfate/Gramicidin Ophthalmic Solution

Reported Side Effects for Neomycin Sulfate/Polymyxin B Sulfate/Gramicidin Ophthalmic Solution

Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Itchy Eyes Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Blurred Vision Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Eye Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Triple Antibiotic

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5